FindTrial
Sign In

Symptom burden management of advanced cancer patients in China

Symptom burden management of advanced cancer patients in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024957
Enrollment
Unknown
Registered
2019-08-05
Start date
2019-08-09
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, gastric cancer, esophagus cancer, liver cancer, colorectal cancer or breast cancer

Interventions

Case series:Nil

Sponsors

Peking University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged greater than or equal to 18 years old; (2) Diagnosis of lung cancer, gastric cancer, esophagus cancer, liver cancer, colorectal cancer or breast cancer, cancer staging for metastatic cancer; (3) Cancer patients in hospital.

Exclusion criteria

Exclusion criteria: (1) Communication difficulties; Language barriers; Writing difficulties; (2) Severe cognitive impairment; Organic brain injury; Dementia.

Design outcomes

Primary

MeasureTime frame
MDASI;—

Secondary

MeasureTime frame
HADS;PHQ-9;EQ-5D-5L;ISI;—

Countries

China

Contacts

Public ContactLili Tang

Peking University Cancer Hospital

tanglili_cpos@126.com+86 010-88196019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026